The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
657 - I'm working on building an app for a pharma client. It's a companion for a drug they market. But I'm concerned that the review section in the App Store will put us at risk of being non-compliant. Do you have any suggestions to help?
DTCA/I, consumer secondary audience
1
Posts
1
Posters
537
Views
1
Watching
-
As the concern is that consumer generated content may contravene the regulations, one option is to deactivate the review section (this may be possible depending on the particular App store in question). Alternatively, you could monitor the reviews and have them corrected or removed if they contravene the regulations. More information on monitoring can be found in the guidance document https://www.paab.ca/resources/Online_Activities.pdf
